17 Deep mutational scanning (DMS) studies exploit the mutational landscape of sequence 18 variation by systematically and comprehensively assaying the effect of single amino acid 19 variants (SAVs) for particular proteins. Different experimental protocols proxy effect through 20 a diversity of measures. We evaluated three early prediction methods trained on traditional 21 variant effect data (PolyPhen-2, SIFT, SNAP2) along with a regression method optimized on 22 2 1
DMS data (Envision). On a common subset of 32,981 SAVs, all methods capture some 23 aspects of variant effects, albeit not the same. Early effect prediction methods correlated 24 slightly more with measurements and better classified binary states (effect or neutral), while 25 Envision predicted better the precise degree of effect. Most surprising was that a simple 26 approach predicting residues conserved in families (found and aligned by PSI-BLAST) in 27 many cases outperformed other methods. All methods predicted beneficial effects (gain-of- Recent human sequencing projects conclude that we all carry about 10,000 single amino 2 acid variants (SAVs) with respect to the "reference genome" [1, 2] . Many of these SAVs are 3 assumed to be neutral, while others might change protein function, contributing to complex 4 phenotypes and causing diseases through a single change. Unfortunately, the gap between 5 SAVs with and without experimental characterization continues to widen [3]: for only one in 6 10,000 of the known SAVs some experimental information is available [4, 5] . On top, many 7 of those for which something is known are disease associations that may be wrong [6] . As 8 long as the ability to interpret SAV effect does not improve, both on the level of the organism 9 and the protein, the promise of precision medicine remains unmet [7-10]. 10 Through the increased efficiency of sequencing, a procedure formerly used primarily 11 in silico [11, 12] has become feasible for experiments, namely assessing the effect of all 12 possible SAVs in a protein. In such deep mutational scanning (DMS) studies, a sequence 13 library with all possible variants is created [13, 14] and exposed to a selection system. In the 14 simplest case, the (logarithmic) difference between sequence frequencies with and without 15 selection pressure yield an effect score for individual or combinations of variants [8, [15] [16] [17] . 16 Variants with beneficial effect on protein function are discovered alongside the more 17 commonly reported deleterious effect variants. DMS therefore aims at measuring the 18 landscape of functional fitness for select proteins [18] . 19 DMS has also been applied to screen proteins for improved drug binding, antibody 20 affinity, using non-native chemical stresses, or non-proteinogenic amino acids, and on 21 synthetic proteins [19] [20] [21] [22] [23] [24] [25] [26] . DMS share objectives with directed evolution experiments which 22 assay a wide range of mutations to engineer proteins with specific purposes. In fact, protein 23 engineering has benefited from DMS studies [14] . 24 4 One major challenge for DMS is the development of an assay to measure effect. 1 Evaluating proteins with multiple functions requires multiple assays [8] . For instance, the 2 effect of variants on Ubiquitin-60S ribosomal protein L40 has been assessed through their 3 direct impact on yeast growth, as well as, through the impaired activation by the E1 enzyme 4 [27, 28] . BRCA1 has been assayed through E3 ubiquitin ligase activity, through BARD1 5 binding and transcript abundance [29, 30] . Even for the same assay, specific experimental 6 conditions might influence measurements [31] . Recently, a protocol for measuring protein 7 abundance has been suggested as a proxy for function and applicable to many proteins [32] . 8 The conclusions from DMS studies are limited by the validity of their functional assays; 9 inferences of more complex effect relationships such as disease risk or clinically actionable 10 pathogenicity often remain too speculative [8, 17] . 11 Long before experimental DMS, prediction methods had addressed the same task in 12 silico [33, 34] [35] [36] [37] [38] [39] [40] [41] . These methods were developed on very limited datasets of effect 13 and neutral variants. Many methods focused on disease-causing SAVs, e.g. from OMIM 14 [42] . Others used databases such as the heterogeneous dbSNP [43] only ten of the 22 sets (45%) scored some variants for at least 98% of the residues (Table   9   S1 ). Four DMS studies provided functional scores for over 90% of all possible 19 non-native 10 SAVs. On average, 66% of the residues in the 22 DMS sets were found to have SAVs with 11 both deleterious and beneficial effects (Table S2 ). The majority of SAVs were beneficial for 3 12 of 22 studies (14%), namely for C-C chemokine receptor type 5 (CCR5), Mitogen-activated also succeeded in detecting SAVs with less pronounced effects ( Fig. 1c-d ).
10 11 Envision approximates experimental values best. When evaluating methods by the 12 numerical difference between experimental and predicted variant effect scores (mean 13 squared error, MSE), Envision was best, followed at considerable distance by SNAP2, 14 PolyPhen-2 and SIFT ( Fig. 1a-d , Table 2 ). Envision was found to best distinguish low from 15 high effect variants [49] . The training as regression method might have given it an 16 advantage over classification methods. Envision's good performance on this metric, partially 17 originated from predicting no SAV with strong effect (the highest Envision score was 0.61, 18 with a possible maximum of 1). Such a distribution resembled the overall experimental 19 distribution that was skewed towards lower effect ( Fig. 1d , gray distributions next to x-and y-20 axes). Predicting most SAVs somewhere in the middle constraints the maximally possible 21 MSE. Indeed, shuffling the prediction scores achieved the same MSE ( Fig. S2a ). 22 Furthermore, predicting a normal distribution around the mean of the experimental values 23 performed slightly worse but still better than all other prediction methods ( Fig. S2b , Table 2 ). 24 On the other hand, MSE did not increase when limiting the evaluation to just the 25% 25 strongest effect SAVs, although the benefit of predicting no strong effect SAVs should be 26 8 reduced here (Table S4 ). When considering each DMS measurement separately, Envision 1 also appeared to perform best except for transcriptional coactivator YAP1 (YAP1) which 2 indeed had the most uniform distribution of effect scores (similar number of lowest, medium, 3 and strongest effects observed; Fig. S3b , Table S5 ). 
Conservation captured deleterious effects well.
Most surprising was the good 6 performance of a naïve method exclusively using conservation (from PSI-BLAST profiles) to 7 predict SAV effects. This naïve prediction appeared to correlate more with the DMS 8 experiments than the specialized methods SIFT and Envision ( Fig. 1e ). Furthermore, the 9 MSE was lower for Conservation than for all specialists except Envision ( Fig. 1 (Table S4) . 16 This suggested beneficial effect SAVs to have distinctly different signatures from their 17 deleterious counterparts, too distinct for current methods to capture. The conservation-18 based prediction also decreased substantially from Spearman ρ of 0.29 for deleterious to -19 0.08 for beneficial SAVs (Table 2, S5j, n, o, t). Possibly, because most SAVs in the development sets of these methods were 25 deleterious. 26 10 Unlike Spearman ρ, the MSE for beneficial effect SAVs was similar to that for 1 deleterious variants. Envision again performed best by far (MSE=0.05, Tables 2, S3 ), also 2 when treating each set separately (Table S8 , Fig. S5 ). Envision was trained with 25% 3 beneficial effect variants (SOM_Note1). However, the decreased correlation performance (ρ 4 = -0.14 versus 0.1), highlighted that just including these variants in training did not suffice to 5 learn their signatures. experiments and Envision (mean MSE=0.07, Table S9 , Table S5 ). 23 In contrast to deleterious SAVs, experiments did not correlate for beneficial effect 24 (mean ρ=0.03) although the MSE remained low (mean MSE=0.05, Table S9 , Fig. S7 ). The 25 major issue for this comparison were the small numbers (572 SAVs from five assays). 26 
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Maybe experimental assays are biased towards measuring deleterious effects. This also put 1 the poor predictions of beneficial SAVs effects into perspective. Fig. 1f , Table S10 ). Precision-recall curves 14 also highlight the smooth transition of SNAP2 opposed to the naïve approach of 15 Conservation although both methods share similar peak performance ( Fig S9) . For this task, 16 for which it had not been developed, Envision performed better than random, but clearly 17 worse than the specialized classification methods (AUC = 0.55 [0.54, 0.56]). On the BRCA1 18 set, Envision performed on par with the best methods ( Fig. S10a ). The reason remained 19 unclear, but for this set correlation was also highest (Table S6) . Overall, the simple 20 assumption that classification methods perform better on the task they were trained for was 21 not supported by our results: The four proteins considered here (BRCA1, PPARG, PTEN 22 and TPMT), also correlated above average for SNAP2, PolyPhen-2 and SIFT (Table S6 ). 23 Using less or more stringent definitions for classifying experimental SAVs Beneficial SAVs were also difficult to classify: PolyPhen-2 and SNAP2 performed 1 best with AUC=0.62, followed by SIFT, while Envision predictions were not better than 2 random ( Fig. S4f, Fig. S11c-d , Table S10 ). Naïve Conservation also performed significantly 3 worse at a level of random predictions. Although binary classification methods, surprisingly, captured aspects of non-binary 8 measurements, they performed much better for the binary classification task (projecting 9 DMS results onto neutral vs. effect; Fig. 1f ). Notably, the naïve Conservation prediction 10 captured effect better than some more advanced tools.
The challenge for the next generation of prediction methods will be to learn from the 12 diversity of DMS. (Table S13 ). In the following processing, effect scores were left as provided by the authors 3 as much as possible but adjusted such that the wild-type score for each measurement 4 ( scores of all methods were adjusted to lie between 0 (no effect) and 1 (highest effect) using 8 the theoretical maximum and minimum prediction value of every method. experiment are depicted in Fig. S1 and Table S1 . 
